Compare Vertex Pharmaceuticals Incorporated (VRTX) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vertex Pharmaceuticals Incorporated vs Verizon Communications Inc — how do they compare? Vertex Pharmaceuticals Incorporated trades at $503.25 (market cap $128.16B), while Verizon Communications Inc trades at $43.73 (market cap $190.16B). The key difference: Verizon Communications Inc is the larger of the two by market cap, and Verizon Communications Inc pays a 6.18% dividend while Vertex Pharmaceuticals Incorporated pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vertex Pharmaceuticals Incorporated for 120 Days and Verizon Communications Inc for 109 Days on average.
| VRTX | VZ | |
|---|---|---|
Market Cap | $128.16B | $190.16B |
Volume | 806,603 | 15,790,993 |
Sector | Health | Media |
52-Week High | $557.96 | $51.45 |
52-Week Low | $407.37 | $38.40 |
Typical Hold Time | 120 Days | 109 Days |
Enterprise Value | $122.29B | $376.87B |
Dividend Yield | — | 6.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Vertex Pharmaceuticals (VRTX) trades at $503.25, showing modest daily gains of 0.16%. The stock faces bearish technical signals with mixed earnings performance, missing Q4 2025 and Q2 2026 EPS estimates but beating Q1 2026. Strong fundamentals include 86% gross margins and 35% net income margins, with revenue projected to grow from $12B to $12.6B in 2026. Recent positive Phase II data for kidney disease drug inaxaplin highlights pipeline progress.
Outlook remains positive with 84% analyst buy ratings and $573 consensus target offering 14% upside. Key risks include reliance on cystic fibrosis franchise and competitive pressures. Earnings consistency and pipeline execution are critical for sustained growth amid current technical weakness.
Verizon (VZ) trades at $46.35, up 0.8% with a bearish technical signal despite recent earnings beats. The stock shows attractive valuation metrics with P/E of 11.9 and dividend yield support, while fundamentals indicate stable revenue growth and strong cash flow generation. Recent corporate developments include board appointments and a joint venture with telecom peers to expand coverage.
Outlook remains balanced with value appeal from dividends and cash flow offset by competitive pressures and debt levels. Key catalysts include Q3 earnings on October 26, 2026, while risks involve industry competition and capital expenditure requirements. Analyst consensus leans hold with $48.58 price target suggesting modest upside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
